ADC Therapeutics (ADCT) PT Raised to $39 at BofA Securities

August 4, 2021 6:51 AM EDT
Get Alerts ADCT Hot Sheet
Price: $28.29 -2.45%

Rating Summary:
    6 Buy, 1 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 5 | New: 36
Trade Now! 
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad raised the price target on ADC Therapeutics (NYSE: ADCT) to $39.00 (from $37.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change